02/05/2019

Newsletters of Interest

A Few Articles You Won’t Want to Miss:

• Let your patients know they can use LabCorp and Quest Diagnostics
• Together for you, Aetna and CVS Health

And Much More….DECEMBER OfficeLink Updates Qtly Issue Available HERE

A Few Articles You Won’t Want to Miss:

• Providers: Don’t issue referrals for BCN Advantage members staying in‑network
• Understanding the difference between ‘home health’ and ‘home infusion’
• Medicare Part B medical specialty drug prior authorization lists
  changing in 2019
• AllianceRx Walgreens Prime specialty pharmacy program starts Jan. 1

And Much More…JANUARY/FEBRUARY Bi-Monthly Issue Available HERE

Current Issue Available HERE

Current Issue Available HERE 
(Once on the site, scroll to the bottom and choose NEWS on the left side)

A Few Articles You Won’t Want to Miss:

• Humana Updates Preauthorization and Notification Lists for 2019
• Changes Announced for 2019 Humana Formularies
• New and Revised Pharmacy and Medical Coverage Policies Available

And Much More…Latest Issue Available HERE

 A Few Articles You Won’t Want to Miss:

• Front & Center
  • UHCTransitions Will Become UHCCareConnect and Be Available through Link
  • Pharmacy Update: Notice of Changes to Prior Authorization Requirements and Coverage Criteria for UnitedHealthcare Commercial and Oxford

• UnitedHealthcare Community 
  • Outpatient Billing for Medications
  • UnitedHealthcare Genetic and Molecular Lab Testing Notification/Prior Authorization Requirement

• UnitedHealthcare Medicare Advantage
  • UnitedHealthcare Medicare Advantage Policy Guideline Updates

And Much More…FEBRUARY Monthly Issue Available HERE

Oncology Related Articles You Won’t Want to Miss:

Medical Policy Updates

Updated:

• Apheresis – Effective Feb. 1, 2019
• Molecular Oncology Testing for Cancer Diagnosis, Prognosis, and Treatment Decisions – Effective Apr. 1, 2019

Medical Benefit Drug Policy Updates

New:

• Gamifant™ (Emapalumab-Lzsg) – Effective Feb. 1, 2019
• Subcutaneous Implantable Hormone Pellets – Effective Feb. 1, 2019
• Subcutaneous Implantable Naltrexone Pellets – Effective Feb. 1, 2019

Revised:

• Clotting Factors, Coagulant Blood Products & Other Hemostatics – Effective Feb. 1, 2019
• White Blood Cell Colony Stimulating Factors – Effective Feb. 1, 2019

Coverage Determination Guideline Updates

Updated:

• Clinical Trials – Effective Feb. 1, 2019

Utilization Review Guideline (URG) Updates

Updated:

• Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Scan – Site of Care – Effective Apr. 1, 2019

Revised:

• Provider Administered Drugs – Site of Care Review Guidelines – Effective Apr. 1, 2019

FEBRUARY Monthly Issue Available HERE